These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10518199)

  • 21. Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress.
    Lokich J
    Cancer Invest; 1999; 17(7):551-4. PubMed ID: 10518201
    [No Abstract]   [Full Text] [Related]  

  • 22. [Perspectives of improvement of chemotherapy effectiveness in disseminated solid tumors].
    Sivashinskiĭ MS
    Vopr Onkol; 2004; 50(2):237-42. PubMed ID: 15176230
    [No Abstract]   [Full Text] [Related]  

  • 23. [Organ-preserving treatment of bladder cancer with combined radiochemotherapy: Do patients profit from additional neoadjuvant chemotherapy?].
    Diestelhorst A; Dunst J
    Strahlenther Onkol; 1999 Aug; 175(8):414-5. PubMed ID: 10481776
    [No Abstract]   [Full Text] [Related]  

  • 24. How strong is the case for intensive cancer chemotherapy?
    Tattersall MH; Tobias JS
    Lancet; 1976 Nov; 2(7994):1071-2. PubMed ID: 62911
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug dosage intensity--a panel discussion.
    McGuire WL; Goldie J; Hryniuk W; Tormey DC
    Breast Cancer Res Treat; 1987; 9(2):87-100. PubMed ID: 3620720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trastuzumab faces trials, clinical and otherwise.
    Tuma RS
    J Natl Cancer Inst; 2006 Mar; 98(5):296-8. PubMed ID: 16507822
    [No Abstract]   [Full Text] [Related]  

  • 27. Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment.
    Padmanabhan R; Meskin N; Haddad WM
    Math Biosci; 2017 Nov; 293():11-20. PubMed ID: 28822813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will increases in dose intensity improve outcome: con.
    Souhami RL
    Am J Med; 1995 Dec; 99(6A):71S-76S. PubMed ID: 8585544
    [No Abstract]   [Full Text] [Related]  

  • 29. Algorithms for scheduling of chemotherapy plans.
    Sevinc S; Sanli UA; Goker E
    Comput Biol Med; 2013 Dec; 43(12):2103-9. PubMed ID: 24290927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Chlebowski RT
    J Natl Cancer Inst; 2010 Jan; 102(2):137. PubMed ID: 20019336
    [No Abstract]   [Full Text] [Related]  

  • 31. Ovarian cancer: is dose intensity dead?
    Ozols RF
    J Clin Oncol; 2007 Sep; 25(27):4157-8. PubMed ID: 17698802
    [No Abstract]   [Full Text] [Related]  

  • 32. The importance of dose and schedule in cancer chemotherapy: breast cancer.
    Leonard RC
    Anticancer Drugs; 1995 Oct; 6 Suppl 5():17-27. PubMed ID: 8845492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
    Schuchter LM
    J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraperitoneal chemotherapy in the management of malignant disease.
    Markman M
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose metronomic chemotherapy: myth or truth?
    Baruchel S; Stempak D
    Onkologie; 2006 Jul; 29(7):305-7. PubMed ID: 16874013
    [No Abstract]   [Full Text] [Related]  

  • 36. A new way to attack cancer.
    Stipp D
    Fortune; 2000 May; 141(11):164-6, 168, 172 passim. PubMed ID: 10947559
    [No Abstract]   [Full Text] [Related]  

  • 37. Emil Frei III, 1924-2013.
    Holland JF; Freireich EJ
    J Clin Oncol; 2013 Oct; 31(30):3727-30. PubMed ID: 24019548
    [No Abstract]   [Full Text] [Related]  

  • 38. [Metronomic chemotherapy in pediatric oncology: hype or hope?].
    André N; Pasquier E; Verschuur A; Sterba J; Gentet JC; Rössler J
    Arch Pediatr; 2009 Aug; 16(8):1158-65. PubMed ID: 19446445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronochemotherapy for cancer].
    Akazawa S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1191-202. PubMed ID: 9279336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A combination phase I/II study--dose escalation plan].
    Yamamoto N
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2267-74. PubMed ID: 11142175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.